Prihlásiť sa Zaregistrujte sa zadarmo

Last updated: 14 April 2023 at 7:24pm EST

Michael Donegan Net Worth




The estimated Net Worth of Michael C Donegan is at least $682 Tisíc dollars as of 12 April 2023. Mr. Donegan owns over 50,000 units of TherapeuticsMD Inc stock worth over $109,968 and over the last 9 years he sold TXMD stock worth over $0. In addition, he makes $572,084 as Vice President - Finance at TherapeuticsMD Inc.

Mr. Donegan TXMD stock SEC Form 4 insiders trading

Michael has made over 6 trades of the TherapeuticsMD Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 50,000 units of TXMD stock worth $88,895 on 12 April 2023.

The largest trade he's ever made was exercising 115,000 units of TherapeuticsMD Inc stock on 30 November 2021 worth over $204,459. On average, Michael trades about 8,599 units every 31 days since 2015. As of 12 April 2023 he still owns at least 61,853 units of TherapeuticsMD Inc stock.

You can see the complete history of Mr. Donegan stock trades at the bottom of the page.





Michael Donegan biography

Michael Donegan serves as Vice President - Finance of the Company. since April 2013. He has served as Vice President – Finance of our company since April 2013. Mr. Donegan has a 28-year background in accounting and finance. From August 2012 to April 2013, Mr. Donegan served as an independent consultant exclusively for our company, where he conceptualized, designed and executed our Sarbanes-Oxley 404 compliance program. From August 2007 to August 2012, Mr. Donegan served as an independent consultant designing and implementing Sarbanes-Oxley 404 compliance programs for various non-accelerated filers and executed on pre-designed Sarbanes-Oxley 404 compliance programs for certain large accelerated filers. From January 2005 to August 2007, Mr. Donegan served as an independent consultant exclusively for Tyco International, where he enhanced and executed the Sarbanes-Oxley 404 compliance model with their corporate headquarters group. From November 2001 to December 2004, Mr. Donegan was Manager of Financial Systems at Tyco International at its global headquarters. From 1994 to 2001, Mr. Donegan held various positions in the global consolidation/SEC reporting group at Sensormatic Electronics Corporation culminating with the acquisition of Sensormatic Electronics Corporation by Tyco International in the fall of 2001 when he was the Manager of Financial Systems. Mr. Donegan began his career at Ernst & Young, LLP where he worked in both the audit and tax departments. Mr. Donegan earned his B.S. in Accounting and his Master of Accounting from the University of Florida.

What is the salary of Michael Donegan?

As the Vice President - Finance of TherapeuticsMD Inc, the total compensation of Michael Donegan at TherapeuticsMD Inc is $572,084. There are 6 executives at TherapeuticsMD Inc getting paid more, with John Milligan having the highest compensation of $1,440,640.



How old is Michael Donegan?

Michael Donegan is 52, he's been the Vice President - Finance of TherapeuticsMD Inc since 2013. There are 14 older and 12 younger executives at TherapeuticsMD Inc. The oldest executive at TherapeuticsMD Inc is Tommy Thompson, 78, who is the Independent Chairman of the Board.

What's Michael Donegan's mailing address?

Michael's mailing address filed with the SEC is 951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431.

Insiders trading at TherapeuticsMD Inc

Over the last 13 years, insiders at TherapeuticsMD Inc have traded over $21,656,853 worth of TherapeuticsMD Inc stock and bought 721,732 units worth $2,299,099 . The most active insiders traders include Cooper C. Collins, Brian Bernick a Robert G Finizio. On average, TherapeuticsMD Inc executives and independent directors trade stock every 29 days with the average trade being worth of $272,607. The most recent stock trade was executed by John C.K. Iv Milligan on 25 October 2019, trading 72,000 units of TXMD stock currently worth $198,000.



What does TherapeuticsMD Inc do?

therapeuticsmd, inc. is an innovative pharmaceutical company exclusively committed to advancing the health of women and championing awareness of their health care issues. we create products to address the unique changes and challenges women experience through every stage of their lives. with momentum fueled by the needs of our customers, we combine entrepreneurial spirit and clinical expertise to develop innovative solutions designed to go beyond what is presently available. this includes a variety of therapies in our pipeline, along with prescription prenatal vitamins under the vitamedmd® and bocagreenmd® brands. see our community guidelines: https://www.therapeuticsmd.com/social-media-community-guidelines



What does TherapeuticsMD Inc's logo look like?

TherapeuticsMD Inc logo

Complete history of Mr. Donegan stock trades at TherapeuticsMD a TherapeuticsMD Inc

Dátum
#
Spoločnosť
 Človek
Trans.
Transakcia
 Počet akcií Cena za akciu Celková cena Počet akcií po Zdroj
12 Apr 2023 TXMD TherapeuticsMD, Inc. Michael C Donegan
Prin. Fin. a Acctg. Officer
 Využitie opcie 50,000 $3.63 $181,500
12 Apr 2023
61,853 ↗
26 Jan 2023 TXMD TherapeuticsMD, Inc. Michael C Donegan
Prin. Fin. a Acctg. Officer
 Využitie opcie 5,940 $5.08 $30,175
26 Jan 2023
13,550 ↗
23 Jan 2023 TXMD TherapeuticsMD, Inc. Michael C Donegan
Prin. Fin. a Acctg. Officer
 Využitie opcie 4,365 $5.32 $23,222
23 Jan 2023
8,919 ↗
6 Dec 2022 TXMD TherapeuticsMD, Inc. Michael C Donegan
Prin. Fin. a Acctg. Officer
 Využitie opcie 3,476 $5.40 $18,770
6 Dec 2022
5,464 ↗
30 Nov 2021 TXMD TherapeuticsMD, Inc. Michael C Donegan
Prin. Fin. a Acctg. Officer
 Využitie opcie 115,000 $0.50 $57,500
30 Nov 2021
129,158 ↗
10 May 2021 TXMD TherapeuticsMD, Inc. Michael C Donegan
Prin. Fin. a Acctg. Officer
 Využitie opcie 19,000 $1.05 $19,950
10 May 2021
19,000 ↗


TherapeuticsMD Inc executives and stock owners

TherapeuticsMD Inc executives and other stock owners filed with the SEC include: